NeXtGen Biologics and Lovell Government Services Partner to Bring Innovative Advanced Wound Care Technology to Federal Healthcare Systems
Summary:** NeXtGen Biologics and Lovell Government Services announced a partnership to supply advanced wound care technologies to federal healthcare systems, including VA and military facilities. The collaboration focuses on regenerative products for chronic wounds like DFUs, leveraging Lovell’s distribution expertise to improve access and outcomes for veterans and active-duty personnel, reducing healing times and amputation risks through evidence-based innovations.
Key Highlights:
- Partnership: NeXtGen’s biologics via Lovell’s federal contracts for VA/military wound care.
- Products: Regenerative grafts and dressings for DFUs and pressure ulcers.
- Impact: Faster healing, lower costs; targets 1M+ veterans with chronic wounds.
- Quote: “Enhances care for those who’ve served; innovation meets need.”
- Date: Nov 10, 2025; Alachua, FL announcement.
Keywords: NeXtGen Biologics, Lovell Government, federal wound care, VA patients, regenerative products